uric acid and alendronate

uric acid has been researched along with alendronate in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bilezikian, JP; Black, DM; Bouxsein, ML; Ensrud, KE; Garnero, P; Greenspan, SL; Lang, TF; McGowan, JA; Palermo, L; Rosen, CJ	1
Akçay, A; Bavbek, N; Inegöl, I; Kanbay, M; Turgut, FH; Uz, E; Yanik, B; Yanik, T	1

Trials

2 trial(s) available for uric acid and alendronate

Article	Year
The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. The New England journal of medicine, 2003, Sep-25, Volume: 349, Issue:13 Topics: Absorptiometry, Photon; Aged; Aged, 80 and over; Alendronate; Biomarkers; Bone Density; Bone Remodeling; Calcium; Collagen; Collagen Type I; Drug Therapy, Combination; Female; Femur Neck; Fractures, Bone; Humans; Injections, Subcutaneous; Lumbar Vertebrae; Middle Aged; Osteoporosis, Postmenopausal; Parathyroid Hormone; Patient Compliance; Peptides; Phosphopeptides; Procollagen; Uric Acid; Vitamin D	2003
The effect of alendronate, risedronate, and raloxifene on renal functions, based on the Cockcroft and Gault method, in postmenopausal women. Renal failure, 2007, Volume: 29, Issue:4 Topics: Aged; Alendronate; Bone Density Conservation Agents; C-Reactive Protein; Calcium; Etidronic Acid; Female; Humans; Kidney; Kidney Function Tests; Male; Middle Aged; Osteoporosis, Postmenopausal; Phosphorus; Raloxifene Hydrochloride; Risedronic Acid; Uric Acid	2007

Article

Year

The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis.

The New England journal of medicine, 2003, Sep-25, Volume: 349, Issue:13

Topics: Absorptiometry, Photon; Aged; Aged, 80 and over; Alendronate; Biomarkers; Bone Density; Bone Remodeling; Calcium; Collagen; Collagen Type I; Drug Therapy, Combination; Female; Femur Neck; Fractures, Bone; Humans; Injections, Subcutaneous; Lumbar Vertebrae; Middle Aged; Osteoporosis, Postmenopausal; Parathyroid Hormone; Patient Compliance; Peptides; Phosphopeptides; Procollagen; Uric Acid; Vitamin D

2003

The effect of alendronate, risedronate, and raloxifene on renal functions, based on the Cockcroft and Gault method, in postmenopausal women.

Renal failure, 2007, Volume: 29, Issue:4

Topics: Aged; Alendronate; Bone Density Conservation Agents; C-Reactive Protein; Calcium; Etidronic Acid; Female; Humans; Kidney; Kidney Function Tests; Male; Middle Aged; Osteoporosis, Postmenopausal; Phosphorus; Raloxifene Hydrochloride; Risedronic Acid; Uric Acid

2007